Innovations in efforts to expand treatment for opioid use disorder.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 31445112.
- Also identified by DOI 10.1016/j.ypmed.2019.105818 and PMC identifier 7081076.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Fewer than 20% of Americans with opioid use disorder receive empirically-supported treatment. There is a critical need for innovative approaches to support expansion of evidence-based opioid treatment, particularly in rural geographic areas so impacted by the current opioid public health crisis. Doing so will require more diverse pathways into treatment, novel pharmacological tools, improved integration and efficiency among treatment modalities, and harm reduction when treatment is not available. In this invited commentary, we review exciting recent efforts to accomplish these aims as well as offer additional considerations for future clinical and research efforts to increase the availability of treatment for opioid use disorder.
Medical subject headings
- Analgesics, Opioid
- Buprenorphine
- Methadone
- Narcotic Antagonists
- Opiate Substitution Treatment
- Opioid-Related Disorders
- Therapies, Investigational